i-Health, Inc., a prominent player in the health technology sector, is headquartered in the United States and operates extensively across North America. Founded in 2001, the company has established itself as a leader in developing innovative health management solutions, particularly in the realm of dietary supplements and wellness products. i-Health's core offerings include a diverse range of vitamins, minerals, and herbal supplements, designed to enhance overall health and well-being. What sets i-Health apart is its commitment to quality and scientific research, ensuring that each product meets rigorous safety and efficacy standards. With a strong market position, i-Health has garnered recognition for its dedication to consumer health, achieving significant milestones in product development and distribution. The company continues to shape the future of health management, making a lasting impact in the wellness industry.
How does i-Health, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
i-Health, Inc.'s score of 97 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
i-Health, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of DSM-Firmenich AG, which means that any climate commitments or emissions data may be inherited from this parent organisation. As part of its corporate family relationship, i-Health, Inc. aligns with the sustainability initiatives and targets set by DSM-Firmenich AG. This includes participation in various climate initiatives such as the Science Based Targets initiative (SBTi), CDP, and RE100, all of which are cascaded down from DSM-Firmenich AG. However, specific reduction targets or achievements for i-Health, Inc. have not been disclosed. In summary, while i-Health, Inc. does not provide its own emissions data or specific climate commitments, it is linked to the broader sustainability efforts of DSM-Firmenich AG, which may influence its environmental strategies moving forward.
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 1,030,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 590,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 8,683,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | 00,000,000,000 | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 |
i-Health, Inc.'s Scope 3 emissions, which increased by 7% last year and increased by approximately 28% since 2016, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 75% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
i-Health, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.